References
E. I. Gusev and V. I. Skvortsova, Cerebral Ischemia [in Russian], Meditsina, Moscow (2001), p. 328.
G. W. Albers, L. R. Caplan, J. E. Easton, et al., “Transient Ischemic Attack – Proposal for a New Definition,” New Eng. J. Med., 347, No. 347, 1713–1716 (2002).
J. Biller and B. B. Love, “Ischemic cerebrovascular disease,” in: Neurology in Clinical Practice. Principles of Diagnosis and Management, W. G. Bradley et al. (eds.), Elsevier Inc., Philadelphia (2004), Chapter 57, pp. 1197–1250.
D. I. Hadjiev and P. P. Mineva, “A reappraisal of the definition and pathophysiology of the transient ischemic attack,” Med. Sci. Monit., 13, No. 3, 50–53 (2007).
P. D. Lyden, G. J. del Zoppo, et al., “The ischemic penumbra and neuronal salvage,” in: Thrombolytic Therapy for Acute Stroke, P. D. Lyden (ed.), Human Press Inc., New Jersey (2005), Chapter 3, pp. 43–64.
S. Prabhakaran, “Reversible brain ischemia: lessons from transient ischemic attack,” Curr. Opin. Neurol., 20, No. 1, 65–70 (2007).
W.-D. Heiss, “Imaging the ischemic penumbra and treatment effects by PET,” Keio J. Med., 50, No. 4, 249–256 (2001).
D. Lee, D.-W. Kang, J. S. Ahn, et al., “Imaging of the ischemic penumbra in acute stroke,” Korean J. Radiol., 6, 64–74 (2005).
R. L. Macdonald and M. Stoodley, “Pathophysiology of cerebral ischemia,” Neurol. Med. Chir., 38, 1–11 (1998).
P. R. Weinstein, S. Hong, and F. R. Sharp, “Molecular identification of the ischemic penumbra,” Stroke, 35, 2666–2670 (2004).
V. I. Skvortsov, “Neuroprotective therapy in ischemic stroke,” Vrach, 6, 26–32 (2004).
M. Yu. Martynov, M. Kushnerova, R. Zalbek, and O. Busse, “A neuroimaging study in patients with transient cerebral circulatory failure,” Nevrol. Zh., 3, No. 5, 24–28 (1998).
J.-C. Baron, “Mapping the ischaemic penumbra with PET: implications for acute stroke treatment,” Cerebrovasc. Dis., 9, 193–201 (1999).
R. L. De La Paz, “Cerebrovascular disease,” Am. J. Neuroradiol., 28, 1197–1199 (2007).
W.-D. Heiss, K. Herholz, H. G. Bocher-Schwarz, et al., “PET, CT, and MR imaging in cerebrovascular disease,” J. Comput. Ass. Tomogr., 10, 903–911 (1986).
A. M. Kaufmann, A. D. Firlik, M. B. Fukui, et al., “Ischemic core and penumbra in human stroke,” Stroke, 30, 93–99 (1999).
J. L. Saver and C. Kidwell, “Neuroimaging in TIAs,” Neurology, 62, Suppl. 6, pp. 22–25 (2004).
N. S. Ward, “Future perspectives in functional neuroimaging in stroke recovery,” Eur. Medicophys., 43, No. 2, 285–294 (2007).
M. Iacoboni, J. C. Baron, R. S. J. Frackowiak, et al., “Emission tomography contribution to clinical neurology,” Clin. Neurophysiol., 110, 2–23 (1999).
J.-C. Baron, “Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications,” Cerebrovasc. Dis., 11, Supplement 1, 2–8 (2001).
K. Herholz and W.-D. Heiss, “Positron emission tomography in clinical neurology,” Mol. Imag. Biol., 6, No. 4, 239–269 (2004).
H. Yamauchi, H. Okazawa, Y. Kishibe, et al., “Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease,” J. Neurol. Neurosurg. Psychiat., 75, 33–37 (2004).
K. Kajimoto, H. Moriwaki, N. Yamada, et al., “Cerebral hemodynamic evaluation using perfusion-weighted magnetic resonance imaging. Comparison with positron emission tomography values in chronic occlusive carotid disease,” Stroke, 34, 1662–1666 (2003).
S. Kuroda, T. Shiga, T. Ishikawa, et al., “Reduced blood row and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases,” J. Nucl. Med., 45, No. 6, 943–949 (2004).
C. P. Derdeyn, T. O. Videen, N. R. Simmons, et al., “Count-based PET method for predicting ischemic stroke in patients with symptomatic carotid arterial occlusion,” Radiology, 212, 499–506 (1999).
M. Imaizumi, K. Kitagawa, K. Hashikawa, et al., “Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases,” Stroke, 33, 2217–2223 (2002).
M. Kobayashi, H. Okazawa, T. Tsuchida, et al., “Diagnosis of misery perfusion using noninvasive 15O-gas PET,” J. Nucl. Med., 47, No. 10, 1581–1586 (2006).
R. H. C. Bisshops, L. J. Kappelle, W. P. T. M. Mali, and J. van der Grond, “Hemodynamic and metabolic changes in transient ischemic attack patients. a magnetic resonance angiography and 1H-magnetic resonance spectroscopy study performed within 3 days of onset of a transient ischemic attack,” Stroke, 33, 110–115 (2002).
J. Astrup, B. K. Sesjo, and L. Symon, “Thresholds in cerebral ischemia: the ischemic penumbra,” Stroke, 12, 723–725 (1981).
E. Bandera, M. Botteri, C. Minelli, et al., “Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke. A systematic review,” Stroke, 37, 1334–1339 (2006).
M. Itoh, J. Hatazawa, C. Pozzilli, et al., “Haemodynamics and oxygen metabolism in patients after reversible ischaemic attack or minor ischaemic stroke assessed with positron emission tomography,” Neuroradiology, 29, No. 5, 416–421 (1987).
D. Perani, P. Gerundini, and G. L. Lenzi, “Cerebral hemispheric and contralateral cerebellar hypoperfusion during a transient ischemic attack,” J. Cereb. Blood Flow Metab., 7, 507–509 (1987).
W.-D. Heiss, L. W. Kracht, A. Thiel, et al., “Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia,” Brain, 124, 20–29 (2001).
S. J. Read, T. Hirano, D. F. Abbott, et al., “Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole,” Neurology, 51, 1617–1621 (1998).
S. Warach, “Tissue viability thresholds in acute stroke: the 4-factor model,” Stroke, 32, 2460–2461 (2001).
C. J. Chen, S. L. Liao, W. Y. Chen, et al., “Cerebral ischemia/reperfusion injury in rat brain: effects of naloxone,” NeuroReport, 12, 1245–1249 (2001).
A. M. Planas, S. Sole, and C. Justicia, “Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia,” Neurobiol. Dis., 8, 834–846 (2001).
M. D. Ginsburg, “Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection. The 2002 Thomas Willis Lecture,” Stroke, 34, 214–223 (2003).
F. R. Sharp, A. Lu, Y. Tang, and D. E. Millhorn, “Multiple molecular penumbras after focal cerebral ischemia,” J. Cereb. Blood Flow Metab., 20, No. 7, 1011–1032 (2000).
D. Saur, R. Bucher, R. Knab, et al., “Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic esonance-defined mismatch areas,” Stroke, 37, 2713–2719 (2006).
P. T. Akins, P. K. Liu, and C. Y. Hsu, “Immediate early gene expression in response to cerebral ischemia. Friend or foe?” Stroke, 27, 1682–1687 (1996).
C. Pastori, M. C. Regondi, L. Librizzi, and M. Curtis, “Early excitability changes in a novel acute model of transient focal ischemia and reperfusion in the in vitro isolated guinea pig brain,” Exp. Neurol., 204, No. 1, 95–105 (2007).
J. M. Mountz, “Nuclear medicine in the rehabilitative treatment evaluation in stroke recovery. Role of diaschisis resolution and cerebral reorganization,” Eur. Medicophys., 43, No. 2, 221–239 (2007).
L. Symon, N. M. Branston, and O. Chikavani, “Ischemic brain edema following middle cerebral artery occlusion in baboons: relationship between regional water content and blood flow at 1 to 2 hours,” Stroke, 10, 184–191 (1979).
F. C. Bakker, C. J. M. Klijn, A. Jennekens-Schinkel, et al., “Cognitive impairment is related to cerebral lactate in patients with carotid artery occlusion and ipsilateral transient ischemic attacks,” Stroke, 34, 1419–1424 (2003).
H. Benveniste, L. W. Hedlund, and G. A. Johnson, “Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy,” Stroke, 23, 746–754 (1992).
D. R. Rutgers, R. C. Donders, E. M. Vriens, et al., “A comparison of cerebral hemodynamic parameters between transient monocular blindness patients, transient ischemic attack patients and control subjects,” Cerebrovasc. Dis., 10, No. 4, 307–314 (2000).
R. A. Crisostomo, M. M. Garcia, and D. C. Tang, “Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics,” Stroke, 34, No. 4, 932–937 (2003).
Y. Inatoma, K. Kimura, T. Yonehara, et al., “DWI abnormalities and clinical characteristics in TIA patients,” Neurology, 62, 376–380 (2004).
P. W. Schaefer, A. Kiruluta, and R. G. Gonzalez, “Diffusion MR of acute stroke,” in: Acute Ischemic Stroke: Imaging and Intervention R. G. Gonzalez et al. (eds.), Springer, Berlin, Heidelberg, New York (2006), Chapter 7, pp. 139–172.
A. K. Kamal, A. Z. Segal, and A. M. Ulu, “Quantitative diffusionweighted MR imaging in transient ischemic attacks,” Am. J. Neuroradiol., 23, 1533–1538 (2002).
J. J. Marx, A. Mika-Gruettner, F. Thoemke, et al., “Diffusion weighted magnetic resonance imaging in the diagnosis of reversible ischaemic deficits of the brainstem,” J. Neurol. Neurosurg. Psychiat., 72, 572–575 (2002).
J. N. E. Redgrave, S. B. Coutts, U. G. Schulz, et al., “Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack,” Stroke, 38, 1482–1488 (2007).
A. Rovira, A. Rovira-Gols, S. Pedruza, et al., “Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks,” Am. J. Neuroradiol., 23, 77–83 (2002).
U. G. Schulz, D. Briley, T. Meagher, et al., “Diffusion-weighted MRI in 300 patients presenting late with subacute transient ischemic attack or minor stroke,” Stroke, 35, 2459–2465 (2004).
C. S. Kidwell, J. R. Alger, F. Di Salle, et al., “Diffusion MRI in patients with transient ischemic attacks,” Stroke, 30, 1174–1180 (1999).
C. Oppenheim, C. Lamy, E. Touzé, et al., “Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions?” Am. J. Neuroradiol., 27, 1782–1787 (2006).
J. Bardutzky, Q. Shen, N. Henninger, et al., “Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging,” Stroke, 38, 1336–1344(2007).
J.-M. Boulanger, S. B. Coutts, M. Eliasziw, et al., “Diffusionweighted imaging-negative patients with transient ischemic attack are at risk of recurrent transient events,” Stroke, 38, 2367–2369 (2007).
F. Purroy, J. Montaner, A. Rovira, et al., “Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions,” Stroke, 35, 2313–2319 (2004).
J. N. E. Redgrave, U. G. Schulz, D. Briley, et al., “Presence of acute ischaemic lesions on diffusion-weighted imaging is associated with clinical predictors of early risk of stroke after transient ischaemic attack,” Cerebrovasc. Dis., 24, No. 1, 86–90 (2007).
P. N. Sylaja, S. B. Coutts, S. Subramaniam, et al., “Acute ischemic lesions of varying ages predict risk of ischemic events in stroke. TIA patients,” Neurology, 68, No. 6, 415–419 (2007).
N. Inoe, K. Sato, T. Maruo, et al., “Diffusion weighted image negative transient ischaemic attack and reversible ischaemic neurological deficit. A report of 10 patients with complete recovery,” J. Clin. Neurosci., 11, No. 6, 619–622 (2004).
C. Lamy, C. Oppenheim, D. Calvet, et al., “Diffusion-weighted MR imaging in transient ischaemic attacks,” Eur. Radiol., 16, No. 5, 1090–1095 (2006).
C. S. Kidwell, J. R. Alger, and J. L. Saver, “Evolving paradigms in neuroimaging of the ischemic penumbra,” Stroke, 35, 2662–2665 (2004).
K. Winbeck, K. Bruckmaier, T. Etgen, et al., “Transient ischemic attack and stroke can be differentiated by analyzing early diffusionweighted imaging signal intensity changes,” Stroke, 35, 1095–1099 (2004).
M. Maeda, M. Ishida, N. Matsushima, et al., “Recanalization and reversal of diffusion abnormalities and markedly reduced cerebral blood volume in a patient with transient ischemic attack,” Clin. Imag., 30, No. 3, 203–210 (2006).
J. Fiehler, M. Foth, T. Kucinski, et al., “Severe ADC decreases do not predict irreversible tissue damage in humans,” Stroke, 33, 79–86 (2002).
J. Fiehler, K. Knudsen, T. Kucinski, et al., “Predictors of apparent diffusion coefficient normalization in stroke patients,” Stroke, 35, 514–519 (2004).
P. E. Grant, J. He, E. F. Halpern, et al., “Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain,” Radiology, 221, 43–50 (2001).
W.-D. Heiss, J. Sobesky, U. V. Smekal, et al., “Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity. A comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke,” Stroke, 35, 1892–1898 (2004).
L. Restrepo, M. A. Jacobs, P. B. Barker, and R. J. Wityk, “Assessment of transient ischemic attack with diffusion- and perfusion-weighted imaging,” Am. J. Neuroradiol., 25, 1645–1652 (2004).
P. N. Sylaja, S. B. Coutts, A. Krol, et al., “When to expect negative diffusion-weighted images in stroke and transient ischemic attack,” Stroke, 39, No. 6, 1898–1900 (2008).
C. Ide, B. De Coene, J. P. Trigaux, et al., “Discrepancy between diffusion and perfusion imaging in a patient with transient ischaemic attack,” J. Neuroradiol., 28, 118–122 (2001).
A. L. Krol, S. B. Coutts, J. E. Simon, et al., “Perfusion MRI abnormalities in speech or motor transient ischemic attack patients,” Stroke, 36, 2487–2489 (2005).
M. Ohashi, A. Tsuji, M. Kaneko, and M. Matsuda, “Threshold of regional cerebral blood flow for infarction in patients with acute cerebral ischemia,” J. Neuroradiol., 32, No. 5, 337–341 (2005).
M. Fisher and M. Ginsberg, “Current concepts of the ischemic penumbra: introduction,” Stroke, 35, 2843–2847 (2004).
J. Sobesky, O. Z. Weber, and F.-G. Lehnhardt, “Which time-to-peak threshold best identifies penumbral row? A comparison of perfusionweighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke,” Stroke, 35, 2843–2847 (2004).
D. G. Darby, P. A. Barber, R. P. Gerraty, et al., “Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI,” Stroke, 30, 2043–2052 (1999).
K. S. Butcher, M. Parsons, L. MacGregor, et al., “Refining the perfusion-diffusion mismatch hypothesis,” Stroke, 36, 1153–1159 (2005).
K. S. Butcher, M. Parsons, L. Allport, et al., “Rapid assessment of perfusion-diffusion mismatch,” Stroke, 39, 75–81 (2008).
W.-D. Heiss, J. Sobesky, and V. Hesselmann, “Identifying thresholds for penumbra and irreversible tissue damage,” Stroke, 35, 2671–2674 (2004).
J. Sobesky, O. Z. Weber, F.-G. Lehnhardt, et al., “Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke,” Stroke, 36, 980–985 (2005).
G. W. Albers, V. N. Thijs, L. Wechsler, et al., “Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study,” Ann. Neurol., 60, 508–517 (2006).
I. Kane, P. Sandercock, and J. Wardlaw, “Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date,” J. Neurol. Neurosurg. Psychiat., 78, 485–491 (2007).
B. S. Geisler, F. Brandhoff, J. Fiehler, et al., “Blood oxygen leveldependent MRI allows metabolic description of tissue at risk in acute stroke patients,” Stroke, 37, 1778–1784 (2006).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 109, No. 10, Stroke, Iss. 2, pp. 26–33, October, 2009.
Rights and permissions
About this article
Cite this article
Belyavskii, N.N., Likhachev, S.A. Pathophysiological aspects of transient ischemic attacks. Neurosci Behav Physi 41, 28–34 (2011). https://doi.org/10.1007/s11055-010-9374-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-010-9374-5